Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Renal Insufficiency, Chronic 1Lymphoma, Follicular 1Diabetes Mellitus 1

Interventions

Metformin 8Surveys and Questionnaires 3Pioglitazone 3Nutrition Assessment 3Methods 3Exercise 3Educational Status 3Tirzepatide 2Therapeutics 2Tablets 2Standard of Care 2Specimen Handling 2Resistance Training 2Interviews as Topic 2Glucose Tolerance Test 2Biopsy 2tocilizumab 1tislelizumab 1sofosbuvir-velpatasvir drug combination 1saxagliptin 1pembrolizumab 1otelixizumab 1nabiximols 1esmolol 1epalrestat 1donafenib 1dapagliflozin 1amlodipine, atorvastatin drug combination 1Verapamil 1Urine Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Mellitus × DM199 × Clear all
NCT03795389 2021-09-13

Study to Assess PK, Safety and Tolerability in Patients With DM and CKD

DiaMedica Therapeutics Inc

Phase 1 Completed
33 enrolled
Lymphoid

Diabetes Mellitus, Lymphoma, Follicular, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡